Pembrolizumab plus cetuximab with neoadjuvant chemotherapy for head and neck squamous cell carcinoma. Yao Z, Wang J, Jiang Y, Zhang Y, et al. Head Neck 2024 Aug 13. doi: 10.1002/hed.27915.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yao Z, Wang J, Jiang Y, Zhang Y, et al. Pembrolizumab plus cetuximab with neoadjuvant chemotherapy for head and neck squamous cell carcinoma. Head Neck 2024 Aug 13. doi: 10.1002/hed.27915.
PMID: 39138647